Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Goldman On Valeant: New Tax Inversion Rules Could Have 'Some' Impact, But Nothing Too Drastic

Invest with Confidence. Are you a financial professional? Stay on top of your portfolio with Benzinga Pro's real-time newsfeed and alerts and never miss a headline again.
Don't miss the chance to try it FREE today.

Valeant Pharmaceuticals Intl Inc VRX 10.03% shares had a strong Tuesday, up 10 percent, after the company's Ad Hoc Committee said it did not identify any additional items beyond the required restatements previously disclosed.

"We see the conclusion of the Ad Hoc Committee review as potentially supporting the expected 10-K filing timeline," Goldman Sachs analysts wrote in a new update on Tuesday afternoon; that filing is expected on or before April 29.

Tax...


More